TELCADIN 80 TAB

About

TELCADIN 80 TAB contains Telmisartan 80mg, an angiotensin II receptor blocker (ARB). This higher dose of Telmisartan is primarily indicated for the treatment of essential hypertension, particularly in patients whose blood pressure is not adequately controlled with lower doses or other antihypertensive agents. It is also used for cardiovascular risk reduction in patients aged 55 years or older who are at high risk of cardiovascular events. Telmisartan works by selectively blocking the AT1 receptors, which are responsible for the vasoconstrictive and aldosterone-secreting effects of angiotensin II. This action leads to vasodilation, reduced aldosterone secretion, and decreased sodium and water reabsorption, resulting in a significant reduction in blood pressure.

The 80mg dose provides potent and sustained blood pressure control, crucial for preventing long-term complications of hypertension such as stroke, myocardial infarction, and kidney disease. Its long duration of action allows for convenient once-daily dosing, ensuring consistent blood pressure management throughout the 24-hour period. Telmisartan is generally well-tolerated and offers a robust option for managing severe or resistant hypertension and for comprehensive cardiovascular protection.

Uses

• Treatment of severe essential hypertension
• Cardiovascular risk reduction in high-risk patients
• Management of resistant hypertension
• Diabetic nephropathy (off-label)

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your physician.

Benefits

• Potent and sustained blood pressure reduction
• Significant cardiovascular risk reduction
• Convenient once-daily dosing regimen
• Effective for resistant hypertension
• Provides renoprotective effects
• Well-tolerated in most patients

Side Effects

• Dizziness
• Headache
• Fatigue
• Cough
• Back pain
• Diarrhea
• Nausea
• Abdominal pain
• Sinusitis
• Pharyngitis
• Muscle cramps
• Hyperkalemia (rare)

Safety Measures

• Alcohol - Alcohol may enhance the hypotensive effects of Telmisartan and increase the risk of dizziness or lightheadedness.
• Pregnancy - Contraindicated, especially during the second and third trimesters, due to potential fetal harm and toxicity.
• Breastfeeding - Not recommended; Telmisartan may pass into breast milk and could affect a nursing infant.
• Liver - Use with caution; dose adjustment may be necessary in patients with severe hepatic impairment.
• Kidney - Contraindicated in severe renal artery stenosis; monitor kidney function closely in all patients.
• Lung - Generally safe; no specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.